ARS Tris-EDTA solution for treating bacterial endometritis in mares. The 90 ml vial with sealed rubber stopper provides three treatments when following the protocols provided in the "Formulary and Protocols in Equine Reproduction" book published by the Colorado State University Equine Reproduction Laboratory.
Bacterial endometritis is an important cause of reduced fertility in mares.
Addition of Tris-EDTA to an antibiotic has been shown to significantly reduce the minimal inhibitory concentration (MIC) of the antibiotic in the prevention of bacterial growth in vitro.
Infusion of Tris-EDTA into the uterus of mares with bacterial endometritis followed by uterine lavage the next day has also been advocated for biofilm disruption prior to infusion of antibiotics.
This product should be used under the advise and recommendation of a veterinarian.
Automatic discounts apply when buying 5-9 (5%) and 10+ (10%) bottles.
Specification | Value |
---|
ARS Part Number | TEDTA-90 |
Volume | 90 ml |
Shelf Life | 6 months from date of manufacture |
ARS
Tris-EDTA and Intrauterine Antibiotic Therapy
Bacterial
endometritis is an important cause of reduced fertility in mares.
Equine
uterine pathogens live in both a free-floating and biofilm state.
Biofilms protect pathogens from the host immune system.
Tris-EDTA
has been shown to potentiate the efficacy of antibiotics in the
killing of bacteria and the disruption of bacterial biofilms.
Tris-EDTA
works in part by chelating Mg2+
and Ca2+ ions
from the outer cell wall of Gram-negative bacteria, allowing for
greater penetration of antibiotics and consequently enhanced
bacterial killing.
Addition
of Tris-EDTA to an antibiotic has been shown to significantly reduce
the minimal inhibitory concentration (MIC) of the antibiotic in the
prevention of bacterial growth in vitro.
Infusion
of Tris-EDTA into the uterus of mares with bacterial endometritis
followed by uterine lavage the next day has also been advocated for
biofilm disruption prior to infusion of antibiotics.
This
product should be used under the advise and recommendation of a
veterinarian.
Tris-EDTA
Protocol for Equine Intrauterine Antibiotic Infusion
Ingredient
|
Amikacin
(250 mg/ml)
|
Gentamicin
(100 mg/ml)
|
Ampicillin
(1 gm/bottle)
|
Ceftiofur
(1 gm/bottle)
|
Antibiotic
|
4 mls (1 gm)
|
10 mls (1 gm)
|
1 gram
|
1 gram
|
Sodium Bicarbonate (8.4 %)*
|
10 mls
|
10 mls
|
n/a
|
n/a
|
Tris-EDTA (ARS)
|
30 mls
|
30 mls
|
30 mls
|
30 mls
|
QS (Sterile Fluid)
|
16 mls
|
10 mls
|
30 mls
|
30 mls
|
Final Volume
|
60 mls
|
60 mls
|
60 mls
|
60 mls
|
*Addition of Sodium Bicarbonate
is needed to buffer the pH of aminoglycoside antibiotics.
References:
Ferris
RA, Wittstock SM, McCue PM, Borlee BR. Evaluation of biofilms in
Gram-negative bacteria isolated from the equine uterus. J Equine Vet
Sci 2014;34:121.
Ferris
RA, McCue PM, Borlee GI, Loncar KD, Hennet ML, Borlee BR. In
vitro efficacy of nonantibiotic treatments on
biofilm disruption of Gram-negative pathogens and an in
vivo model of infectious endometritis
utilizing isolates from the equine uterus. Journal of Clinical
Microbiology 2016;54(3):631-9.
Loncar
KD, Ferris RR, McCue P, Borlee BR, Hennet ML, Borlee GI. In
vitro efficacy of non-antibiotic agents
against bacterial biofilm from equine uterine isolates. Proceedings
of the American Association of Equine Practitioners 2015;61:458-459.